Fielmann Aktiengesellschaft (FIE.DE)
EUR 41.9
(2.07%)
EUR 41.9
(2.07%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.2 Billion EUR | 33.05% |
| 2022 | 909.1 Million EUR | 5.33% |
| 2021 | 863.08 Million EUR | 3.63% |
| 2020 | 832.85 Million EUR | 30.15% |
| 2019 | 639.93 Million EUR | 171.65% |
| 2018 | 235.57 Million EUR | 2.13% |
| 2017 | 230.67 Million EUR | 1.5% |
| 2016 | 227.26 Million EUR | 1.77% |
| 2015 | 223.31 Million EUR | 7.51% |
| 2014 | 207.71 Million EUR | 1.35% |
| 2013 | 204.94 Million EUR | 12.56% |
| 2012 | 182.07 Million EUR | 3.49% |
| 2011 | 175.93 Million EUR | 7.87% |
| 2010 | 163.1 Million EUR | -1.17% |
| 2009 | 165.03 Million EUR | -11.48% |
| 2008 | 186.44 Million EUR | 10.12% |
| 2007 | 169.31 Million EUR | 13.41% |
| 2006 | 149.29 Million EUR | 2.91% |
| 2005 | 145.07 Million EUR | 31.26% |
| 2004 | 110.52 Million EUR | -47.67% |
| 2003 | 211.2 Million EUR | 76.12% |
| 2002 | 119.91 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.23 Billion EUR | 0.0% |
| 2024 Q1 | - EUR | -100.0% |
| 2023 Q1 | 936.43 Million EUR | 3.01% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q2 | 903.93 Million EUR | -3.47% |
| 2023 Q4 | 1.06 Billion EUR | 0.0% |
| 2023 FY | 1.2 Billion EUR | 33.05% |
| 2022 Q2 | 852.1 Million EUR | -3.19% |
| 2022 Q1 | 880.22 Million EUR | 1.99% |
| 2022 Q3 | 863.92 Million EUR | 1.39% |
| 2022 FY | 909.1 Million EUR | 5.33% |
| 2022 Q4 | 909.1 Million EUR | 5.23% |
| 2021 Q1 | 838.98 Million EUR | 0.74% |
| 2021 Q3 | 869.98 Million EUR | 6.09% |
| 2021 Q4 | 863.08 Million EUR | -0.79% |
| 2021 FY | 863.08 Million EUR | 3.63% |
| 2021 Q2 | 820.01 Million EUR | -2.26% |
| 2020 Q3 | 635.76 Million EUR | 2.01% |
| 2020 FY | 832.85 Million EUR | 30.15% |
| 2020 Q4 | 832.85 Million EUR | 31.0% |
| 2020 Q2 | 623.26 Million EUR | -5.91% |
| 2020 Q1 | 662.44 Million EUR | 3.52% |
| 2019 Q4 | 639.93 Million EUR | -4.38% |
| 2019 Q3 | 669.24 Million EUR | 4.27% |
| 2019 Q2 | 641.83 Million EUR | -0.89% |
| 2019 FY | 639.93 Million EUR | 171.65% |
| 2019 Q1 | 647.61 Million EUR | 174.9% |
| 2018 Q3 | 264.85 Million EUR | 14.76% |
| 2018 Q1 | 246.7 Million EUR | 6.95% |
| 2018 FY | 235.57 Million EUR | 2.13% |
| 2018 Q2 | 230.78 Million EUR | -6.46% |
| 2018 Q4 | 235.57 Million EUR | -11.05% |
| 2017 FY | 230.67 Million EUR | 1.5% |
| 2017 Q4 | 230.67 Million EUR | -5.23% |
| 2017 Q3 | 243.4 Million EUR | 3.08% |
| 2017 Q2 | 236.13 Million EUR | -4.06% |
| 2017 Q1 | 246.11 Million EUR | 8.29% |
| 2016 Q2 | 230.3 Million EUR | -0.15% |
| 2016 FY | 227.26 Million EUR | 1.77% |
| 2016 Q4 | 227.26 Million EUR | -5.32% |
| 2016 Q3 | 240.03 Million EUR | 4.23% |
| 2016 Q1 | 230.66 Million EUR | 3.29% |
| 2015 FY | 223.31 Million EUR | 7.51% |
| 2015 Q1 | 236.7 Million EUR | 13.96% |
| 2015 Q4 | 223.31 Million EUR | -5.46% |
| 2015 Q3 | 236.21 Million EUR | 5.76% |
| 2015 Q2 | 223.34 Million EUR | -5.65% |
| 2014 Q2 | 228.45 Million EUR | -5.84% |
| 2014 Q1 | 242.63 Million EUR | 18.39% |
| 2014 FY | 207.71 Million EUR | 1.35% |
| 2014 Q4 | 207.71 Million EUR | -12.25% |
| 2014 Q3 | 236.71 Million EUR | 3.61% |
| 2013 Q1 | 205.17 Million EUR | 12.69% |
| 2013 FY | 204.94 Million EUR | 12.56% |
| 2013 Q4 | 204.94 Million EUR | -4.89% |
| 2013 Q3 | 215.47 Million EUR | 5.91% |
| 2013 Q2 | 203.44 Million EUR | -0.85% |
| 2012 Q4 | 182.07 Million EUR | -6.0% |
| 2012 Q3 | 193.7 Million EUR | -0.62% |
| 2012 Q2 | 194.91 Million EUR | -4.4% |
| 2012 Q1 | 203.88 Million EUR | 15.88% |
| 2012 FY | 182.07 Million EUR | 3.49% |
| 2011 Q3 | 194.51 Million EUR | 7.94% |
| 2011 Q1 | 191.33 Million EUR | 17.31% |
| 2011 Q2 | 180.2 Million EUR | -5.82% |
| 2011 Q4 | 175.93 Million EUR | -9.55% |
| 2011 FY | 175.93 Million EUR | 7.87% |
| 2010 Q3 | 189.42 Million EUR | 0.57% |
| 2010 FY | 163.1 Million EUR | -1.17% |
| 2010 Q4 | 163.1 Million EUR | -13.9% |
| 2010 Q1 | 187.3 Million EUR | 13.49% |
| 2010 Q2 | 188.36 Million EUR | 0.56% |
| 2009 FY | 165.03 Million EUR | -11.48% |
| 2009 Q4 | 165.03 Million EUR | 0.0% |
| 2008 FY | 186.44 Million EUR | 10.12% |
| 2007 FY | 169.31 Million EUR | 13.41% |
| 2006 FY | 149.29 Million EUR | 2.91% |
| 2005 FY | 145.07 Million EUR | 31.26% |
| 2004 FY | 110.52 Million EUR | -47.67% |
| 2003 FY | 211.2 Million EUR | 76.12% |
| 2002 FY | 119.91 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 539.64 Million EUR | -124.142% |
| Carl Zeiss Meditec AG | 860.02 Million EUR | -40.645% |
| Gerresheimer AG | 1.95 Billion EUR | 38.185% |
| Sartorius Aktiengesellschaft | 6.99 Billion EUR | 82.715% |
| Sartorius Aktiengesellschaft | 6.99 Billion EUR | 82.715% |